SCYNEXIS to Present Data at ACOG 2019 Further Demonstrating the Favorable Profile of Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis (VVC)
Stock Information for Fuel Tech Inc.
Loading
Please wait while we load your information from QuoteMedia.